News
The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency, reproducibility, and ...
The NHS has begun giving patients a new DIY heart monitor which looks for heart rhythm problems. Traditional monitors can require lengthy set-up by a trained physiologist, but the new kit can be sent ...
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and ...
5don MSN
Veteran broadcaster Derryn Hinch has opened up about his ongoing health challenges, but age hasn’t slowed the 81-year old down.
Announced FDA clearance of IND application for novel IRAK4 degrader GS-6791/NX-0479, enabling collaboration partner Gilead to initiate Phase 1 trial SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- ...
There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.
For patients with atrial fibrillation, catheter ablation reduces the risk of ischemic stroke at more than 30 days, mortality, ...
Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...
Atrial fibrillation (AF) is the most widespread sustained cardiac arrhythmia globally, significantly contributing to increased morbidity, mortality, and ...
Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...
Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results